One of the UK’s leading clinical trials organisations, MAC Clinical Research, is searching for paid volunteers to take part in a trial testing a new, potentially life-changing treatment for those with COPD.

In the UK it’s estimated that an astounding three million people have Chronic Obstructive Pulmonary Disease (COPD), two million of which don’t even realise they have it – living with recurring, undiagnosed symptoms.

Dr Abimbola Babajide, Primary Investigator at MAC Clinical Research said: “It’s essential we raise awareness of COPD and potential new treatments, to support both those living with diagnosed and undiagnosed COPD.

For those living with COPD, day-to-day life can be tough. The disease causes swelling and destruction of the lungs, resulting in intolerable symptoms such as a persistent chesty cough, shortness of breath, and sputum production.

Even more, COPD is generally a progressive disease that gets worse over time and is associated with flare-ups or exacerbations. That’s why MAC Clinical Research are trialling a new study drug that may treat moderate to very severe COPD associated with elevated blood eosinophils and history of frequent exacerbation.”

The new potential treatment being trialled by MAC Clinical Research is being developed as an ad-on maintenance treatment for the prevention of exacerbations in patients with COPD– assisting the primary COPD medication already taken (triple therapy inhalers).

To be eligible to take part, volunteers must:

  • Be aged between 40 – 85 years
  • Be a current smoker or ex-smoker with a tobacco history of at least 20 cigarettes smoked per day for 10 years
  • History of moderate to very severe COPD
  • Documented history of more than 2 COPD flare-ups requiring treatment with strong steroids and/or hospitalization within the last 12 months
  • Use of triple therapy inhalers for COPD for at least 3 months immediately prior to enrolment

Volunteers will receive up to £850 in total over a 56-week period, and £50 per visit thereafter, plus travel expenses. Participants will also receive a full health screening, with all results being sent to their physician or GP.

To find out more, and help discover potentially life-changing new treatments, visit:

Source link